US FDA Commissioner Scott Gottlieb has been getting generally high marks from the agency’s external stakeholders, and it seems he is just as popular with some of the key managers who report to him.
Three FDA center directors – Janet Woodcock (Center for Drug Evaluation & Research), Peter Marks (Center for Biologics Evaluation & Research) and Richard Pazdur (Oncology Center of Excellence) – were asked to talk about the experience of working for